BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Manne U, Shanmugam C, Katkoori VR, Bumpers HL, Grizzle WE. Development and progression of colorectal neoplasia. Cancer Biomark. 2010;9:235-265. [PMID: 22112479 DOI: 10.3233/cbm-2011-0160] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Franchi M, Karamanos K, Cappadone C, Calonghi N, Greco N, Franchi L, Onisto M, Masola V. Substrate Type and Concentration Differently Affect Colon Cancer Cells Ultrastructural Morphology, EMT Markers, and Matrix Degrading Enzymes. Biomolecules 2022;12:1786. [DOI: 10.3390/biom12121786] [Reference Citation Analysis]
2 Tajasuwan L, Kettawan A, Rungruang T, Wunjuntuk K, Prombutara P, Muangnoi C, Kettawan AK. Inhibitory Effect of Dietary Defatted Rice Bran in an AOM/DSS-Induced Colitis-Associated Colorectal Cancer Experimental Animal Model. Foods 2022;11:3488. [DOI: 10.3390/foods11213488] [Reference Citation Analysis]
3 Shi JL, Lv YH, Huang J, Huang X, Liu Y. Patients with inflammatory bowel disease and post-inflammatory polyps have an increased risk of colorectal neoplasia: A meta-analysis. World J Clin Cases 2022; 10(3): 966-984 [DOI: 10.12998/wjcc.v10.i3.966] [Reference Citation Analysis]
4 Nannini G, Meoni G, Tenori L, Ringressi MN, Taddei A, Niccolai E, Baldi S, Russo E, Luchinat C, Amedei A. Fecal metabolomic profiles: A comparative study of patients with colorectal cancer vs adenomatous polyps. World J Gastroenterol 2021; 27(38): 6430-6441 [PMID: 34720532 DOI: 10.3748/wjg.v27.i38.6430] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Mahmud KM, Niloy MS, Shakil MS, Islam MA. Ruthenium Complexes: An Alternative to Platinum Drugs in Colorectal Cancer Treatment. Pharmaceutics 2021;13:1295. [PMID: 34452256 DOI: 10.3390/pharmaceutics13081295] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
6 Rohr M, Beardsley J, Nakkina SP, Zhu X, Aljabban J, Hadley D, Altomare D. A merged microarray meta-dataset for transcriptionally profiling colorectal neoplasm formation and progression. Sci Data 2021;8:214. [PMID: 34381057 DOI: 10.1038/s41597-021-00998-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Solis-Hernandez MP, Martín C, García B, Pérez-López N, García-Mesa Y, González-Fernández S, García-Suárez O, Merayo J, Fernández-Vega I, Quirós LM. The Genes Encoding Small Leucine-Rich Proteoglycans Undergo Differential Expression Alterations in Colorectal Cancer, Depending on Tumor Location. Cells 2021;10:2002. [PMID: 34440771 DOI: 10.3390/cells10082002] [Reference Citation Analysis]
8 Lastraioli E, Fraser SP, Guzel RM, Iorio J, Bencini L, Scarpi E, Messerini L, Villanacci V, Cerino G, Ghezzi N, Perrone G, Djamgoz MBA, Arcangeli A. Neonatal Nav1.5 Protein Expression in Human Colorectal Cancer: Immunohistochemical Characterization and Clinical Evaluation. Cancers (Basel) 2021;13:3832. [PMID: 34359733 DOI: 10.3390/cancers13153832] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Mehrzad J, Dayyani M, Erfanian-Khorasani M. The independent and combined effects of selected risk factors and Arg399Gln XRCC1 polymorphism in the risk of colorectal cancer among an Iranian population. Med J Islam Repub Iran 2020;34:75. [PMID: 33306066 DOI: 10.34171/mjiri.34.75] [Reference Citation Analysis]
10 Monedeiro F, Monedeiro-Milanowski M, Ligor T, Buszewski B. A Review of GC-Based Analysis of Non-Invasive Biomarkers of Colorectal Cancer and Related Pathways. J Clin Med 2020;9:E3191. [PMID: 33019642 DOI: 10.3390/jcm9103191] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
11 Musumeci L, Oury C, Lancellotti P. Cuando el corazón depende del tracto digestivo. Revista Española de Cardiología 2020;73:702-704. [DOI: 10.1016/j.recesp.2020.03.005] [Reference Citation Analysis]
12 Meng X, Zhang J, Wu H, Yu D, Fang X. Akkermansia muciniphila Aspartic Protease Amuc_1434* Inhibits Human Colorectal Cancer LS174T Cell Viability via TRAIL-Mediated Apoptosis Pathway. Int J Mol Sci 2020;21:E3385. [PMID: 32403433 DOI: 10.3390/ijms21093385] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
13 Leman JKH, Munoz-Erazo L, Kemp RA. The Intestinal Tumour Microenvironment. Adv Exp Med Biol 2020;1226:1-22. [PMID: 32030672 DOI: 10.1007/978-3-030-36214-0_1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
14 Sabry D, El-Deek SEM, Maher M, El-Baz MAH, El-Bader HM, Amer E, Hassan EA, Fathy W, El-Deek HEM. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway. Mol Cell Biochem 2019;454:177-89. [PMID: 30357530 DOI: 10.1007/s11010-018-3462-1] [Cited by in Crossref: 61] [Cited by in F6Publishing: 68] [Article Influence: 15.3] [Reference Citation Analysis]
15 Pandurangan AK, Divya T, Kumar K, Dineshbabu V, Velavan B, Sudhandiran G. Colorectal carcinogenesis: Insights into the cell death and signal transduction pathways: A review. World J Gastrointest Oncol 2018;10:244-59. [PMID: 30254720 DOI: 10.4251/wjgo.v10.i9.244] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 48] [Article Influence: 11.0] [Reference Citation Analysis]
16 Crespo A, García-Suárez O, Fernández-Vega I, Solis-Hernandez MP, García B, Castañón S, Quirós LM. Heparan sulfate proteoglycans undergo differential expression alterations in left sided colorectal cancer, depending on their metastatic character. BMC Cancer 2018;18:687. [PMID: 29940912 DOI: 10.1186/s12885-018-4597-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
17 Bohorquez M, Sahasrabudhe R, Criollo A, Sanabria-Salas MC, Vélez A, Castro JM, Marquez JR, Mateus G, Bolaños F, Panqueva C, Restrepo JI, Puerta JD, Murillo R, Bravo MM, Hernández G, Rios A, Prieto R, Tomlinson I, Echeverry M, Carvajal-Carmona LG. Clinical manifestations of colorectal cancer patients from a large multicenter study in Colombia. Medicine (Baltimore) 2016;95:e4883. [PMID: 27749544 DOI: 10.1097/MD.0000000000004883] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
18 Manne U, Jadhav T, Putcha BK, Samuel T, Soni S, Shanmugam C, Suswam EA. Molecular Biomarkers of Colorectal Cancer and Cancer Disparities: Current Status and Perspective. Curr Colorectal Cancer Rep 2016;12:332-44. [PMID: 28626361 DOI: 10.1007/s11888-016-0338-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
19 Fernández-Vega I, García-Suárez O, García B, Crespo A, Astudillo A, Quirós LM. Heparan sulfate proteoglycans undergo differential expression alterations in right sided colorectal cancer, depending on their metastatic character. BMC Cancer 2015;15:742. [PMID: 26482785 DOI: 10.1186/s12885-015-1724-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
20 Aherne ST, Madden SF, Hughes DJ, Pardini B, Naccarati A, Levy M, Vodicka P, Neary P, Dowling P, Clynes M. Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression. BMC Cancer 2015;15:329. [PMID: 25924769 DOI: 10.1186/s12885-015-1327-5] [Cited by in Crossref: 72] [Cited by in F6Publishing: 74] [Article Influence: 10.3] [Reference Citation Analysis]
21 Arvelo F, Sojo F, Cotte C. Biology of colorectal cancer. Ecancermedicalscience 2015;9:520. [PMID: 25932044 DOI: 10.3332/ecancer.2015.520] [Cited by in Crossref: 67] [Cited by in F6Publishing: 79] [Article Influence: 9.6] [Reference Citation Analysis]
22 Chirica M, Le Bourhis L, Lehmann-Che J, Chardiny V, Bouhidel F, Foulboeuf L, Gornet JM, Lourenco N, Dulphy N, Toubert A, Allez M. Phenotypic analysis of T cells infiltrating colon cancers: Correlations with oncogenetic status. Oncoimmunology. 2015;4:e1016698. [PMID: 26405567 DOI: 10.1080/2162402x.2015.1016698] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
23 Ahmed S, Johnson K, Ahmed O, Iqbal N. Advances in the management of colorectal cancer: from biology to treatment. Int J Colorectal Dis 2014;29:1031-42. [PMID: 24953060 DOI: 10.1007/s00384-014-1928-5] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 6.1] [Reference Citation Analysis]
24 Koehler BC, Jäger D, Schulze-Bergkamen H. Targeting cell death signaling in colorectal cancer: Current strategies and future perspectives. World J Gastroenterol 2014; 20(8): 1923-1934 [PMID: 24587670 DOI: 10.3748/wjg.v20.i8.1923] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
25 Wierzbicki PM, Adrych K, Kartanowicz D, Stanislawowski M, Kowalczyk A, Godlewski J, Skwierz-Bogdanska I, Celinski K, Gach T, Kulig J, Korybalski B, Kmiec Z. Underexpression of LATS1 TSG in colorectal cancer is associated with promoter hypermethylation. World J Gastroenterol 2013; 19(27): 4363-4373 [PMID: 23885148 DOI: 10.3748/wjg.v19.i27.4363] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]